Human Parechovirus Central Nervous System Infection in a Young Infant Cohort

In 2022, a surge in cases of pediatric human parechovirus (HPeV) central nervous system infections in young infants was seen at our institution. Despite the dramatic increase in the number of cases seen that year, the clinical features of the illness were similar to prior years. The recent pediatric...

Descripción completa

Detalles Bibliográficos
Autores principales: Katragkou, Aspasia, Sheth, Avni, Gagliardo, Christina, Aquino, Jessica, Shah, Niva, Nwaobasi-Iwuh, Eberechi, Melchionne, Christina, Black, Paige, Chiu, Stephanie, Di Pentima, Cecilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629600/
https://www.ncbi.nlm.nih.gov/pubmed/37851979
http://dx.doi.org/10.1097/INF.0000000000004122
Descripción
Sumario:In 2022, a surge in cases of pediatric human parechovirus (HPeV) central nervous system infections in young infants was seen at our institution. Despite the dramatic increase in the number of cases seen that year, the clinical features of the illness were similar to prior years. The recent pediatric HPeV surge highlights the need to evaluate treatment options and standardize follow-up to better understand the long-term prognosis of infants with HPeV infection.

Ejemplares similares